Respiratory and sleep Archives - Page 8 of 14

Videos

Olopatadine hydrochloride & mometasone furoate combination nasal spray for allergic rhinitis & rhinoconjunctivitis

In this Product Explainer, Rhinologist Prof Richard Harvey explains the role of olopatadine hydrochloride and mometasone furoate combination nasal spray in the treatment of symptoms associated with allergic rhinitis and rhinoconjunctivitis in patients 6 years of age and older (5 mins).

Podcasts

Obstructive sleep apnea and driving – Ausroads fitness to drive guidelines and the role of GPs

If a person presents with high level of sleepiness or setting them for sleep apnea, driving needs to be considered

Podcasts

COPD and triple therapy: When we should and shouldn’t use it – Your questions answered

The questions answered in this podcast are listed below. They were compiled by GPs and health professionals around Australia.

Clinical Articles

ICS for COPD – Understanding the risks and benefits

Triple therapy for COPD has very different risk/benefits compared to asthma.

Clinical Articles

Common GP emergencies: Asthma

A quick refresher on how to treat an asthma emergency.

Podcasts

Asthma, asthma pharmacology and lung function testing

Asthma needs to be diagnosed effectively. Need objective evidence for the presence of asthma and if it suggests it’s something there’s opportunity to escalate investigation to tertiary care

Videos

Azelastine hydrochloride and fluticasone propionate nasal spray for the management of seasonal allergic rhinitis

In this Product Explainer, Rhinologist and Skull Base Surgeon A/Prof Raewyn Campbell explains the role of azelastine hydrochloride and fluticasone propionate nasal spray in the management of seasonal allergic rhinitis (5 mins).

Podcasts

Insomnia assessment and management for GPs: Part 2 – behavioural treatments for insomnia

There is a massive magnitude of people suffering from insomnia. It’s important to talk about insomnia and manage it well

Podcasts

Insomnia assessment and management/referral options for GPs: Part 1

Insomnia and sleep disorders are quite common and have a range of medications available

Clinical Articles

How do I stop my mind racing and get some sleep?

Martin turns off the light to fall asleep, but his mind quickly springs into action. Racing thoughts about work deadlines, his overdue car service, and his father’s recent surgery occupy his mind.

Clinical Articles

Overuse of oral corticosteroids in asthma & COPD kills

Not everyone benefits equally, and with 3X risk of pneumonia from one course, it’s important to prescribe wisely…

Clinical Articles

‘The dirty disease’ – both smokers and non-smokers get lung cancer. They face stigma on top of illness

Earlier this year, federal health minister Mark Butler announced a new national Lung Cancer Screening Program. The first of its kind for lung cancer, the screening program will open initially to current and former smokers aged 50 to 70 years by July 2025. It aims to save lives by detecting lung cancer earlier.

Respiratory and sleep

Olopatadine hydrochloride & mometasone furoate combination nasal spray for allergic rhinitis & rhinoconjunctivitis

In this Product Explainer, Rhinologist Prof Richard Harvey explains the role of olopatadine hydrochloride and mometasone furoate combination nasal spray in the treatment of symptoms associated with allergic rhinitis and rhinoconjunctivitis in patients 6 years of age and older (5 mins).

Obstructive sleep apnea and driving – Ausroads fitness to drive guidelines and the role of GPs

If a person presents with high level of sleepiness or setting them for sleep apnea, driving needs to be considered

COPD and triple therapy: When we should and shouldn’t use it – Your questions answered

The questions answered in this podcast are listed below. They were compiled by GPs and health professionals around Australia.

ICS for COPD – Understanding the risks and benefits

Triple therapy for COPD has very different risk/benefits compared to asthma.

Common GP emergencies: Asthma

A quick refresher on how to treat an asthma emergency.

Asthma, asthma pharmacology and lung function testing

Asthma needs to be diagnosed effectively. Need objective evidence for the presence of asthma and if it suggests it’s something there’s opportunity to escalate investigation to tertiary care

Azelastine hydrochloride and fluticasone propionate nasal spray for the management of seasonal allergic rhinitis

In this Product Explainer, Rhinologist and Skull Base Surgeon A/Prof Raewyn Campbell explains the role of azelastine hydrochloride and fluticasone propionate nasal spray in the management of seasonal allergic rhinitis (5 mins).

Insomnia assessment and management for GPs: Part 2 – behavioural treatments for insomnia

There is a massive magnitude of people suffering from insomnia. It’s important to talk about insomnia and manage it well

Insomnia assessment and management/referral options for GPs: Part 1

Insomnia and sleep disorders are quite common and have a range of medications available

How do I stop my mind racing and get some sleep?

Martin turns off the light to fall asleep, but his mind quickly springs into action. Racing thoughts about work deadlines, his overdue car service, and his father’s recent surgery occupy his mind.

Overuse of oral corticosteroids in asthma & COPD kills

Not everyone benefits equally, and with 3X risk of pneumonia from one course, it’s important to prescribe wisely…

‘The dirty disease’ – both smokers and non-smokers get lung cancer. They face stigma on top of illness

Get the app

Site

Company

Connect

Legal

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.

Respiratory and sleep

In this Product Explainer, Rhinologist Prof Richard Harvey explains the role of olopatadine hydrochloride and mometasone furoate combination nasal spray in the treatment of symptoms associated with allergic rhinitis and rhinoconjunctivitis in patients 6 years of age and older (5 mins).

If a person presents with high level of sleepiness or setting them for sleep apnea, driving needs to be considered

The questions answered in this podcast are listed below. They were compiled by GPs and health professionals around Australia.

Triple therapy for COPD has very different risk/benefits compared to asthma.

A quick refresher on how to treat an asthma emergency.

Asthma needs to be diagnosed effectively. Need objective evidence for the presence of asthma and if it suggests it’s something there’s opportunity to escalate investigation to tertiary care

In this Product Explainer, Rhinologist and Skull Base Surgeon A/Prof Raewyn Campbell explains the role of azelastine hydrochloride and fluticasone propionate nasal spray in the management of seasonal allergic rhinitis (5 mins).

There is a massive magnitude of people suffering from insomnia. It’s important to talk about insomnia and manage it well

Insomnia and sleep disorders are quite common and have a range of medications available

Martin turns off the light to fall asleep, but his mind quickly springs into action. Racing thoughts about work deadlines, his overdue car service, and his father’s recent surgery occupy his mind.

Not everyone benefits equally, and with 3X risk of pneumonia from one course, it’s important to prescribe wisely…

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Extra Details

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.